# Treatment Strategy to Enhance Nrf2 Signaling in Older Adults

> **NCT04848792** · NA · COMPLETED · sponsor: **Northern Arizona University** · enrollment: 32 (actual)

## Conditions studied

- Aging Problems

## Interventions

- **DIETARY_SUPPLEMENT:** Sulforaphane
- **DIETARY_SUPPLEMENT:** Placebo capsules

## Key facts

- **NCT ID:** NCT04848792
- **Lead sponsor:** Northern Arizona University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-02-09
- **Primary completion:** 2025-05-27
- **Final completion:** 2025-05-27
- **Target enrollment:** 32 (ACTUAL)
- **Last updated:** 2025-08-28

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04848792

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04848792, "Treatment Strategy to Enhance Nrf2 Signaling in Older Adults". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT04848792. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*